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Aortic stenosis and CT calcium scoring:
is it for everyone?
Timothy R G Cartlidge, Tania A Pawade, Marc R Dweck
The evaluation of aortic stenosis (AS)
severity is routinely performed using echo-
cardiography. Current guidelines recom-
mend integrating data with respect to the
peak aortic valve jet velocity, the mean
transvalvular gradient and the aortic valve
area (AVA) calculated by the continuity
equation.1 For the majority of patients this
assessment works well. However in a
third of subjects there is discrepancy in the
results provided by these different mea-
sures.2 Most commonly this takes the form
of an AVA <1.0 cm2 indicating severe
stenosis but a peak velocity <4 m/s and
mean gradient (MG) <40 mm Hg consist-
ent with moderate disease. While this can
sometimes be explained by a low-flow
status this is often not the case.3 What
then to do in that common situation?
Major interest now surrounds CTcalcium
scoring of the valve as an assessment of AS
severity in cases where echocardiographic
measurements are conflicting.4 This is of
particular appeal because calcification is
believed to be the predominant process
driving AS progression and because it pro-
vides a flow-independent assessment of
severity.5 Complex categorisation of pat-
ients based upon flow status and systolic
function is therefore not required.
The last few years have witnessed rapid
advances in this field. Aortic valve CT
calcium scoring has demonstrated a close
association with haemodynamic mea-
sures of AS on Doppler echocardiography
and offers powerful prediction of future
disease progression.2 6 Moreover we now
have proposed cut-offs for differentiating
moderate from severe disease (men
2065 AU, women 1274 AU) that provide
powerful prognostic information over
and above standard echocardiographic
indices.7 However, before CT calcium
scoring translates into clinical practice it is
imperative that we are able to interpret its
results in all the different types of patients
affected by the disease. For example it has
become evident that there are differences
in CT calcium scoring between the sexes
with women requiring less calcium than
men to develop severe stenosis (even after
indexing for body size), perhaps reflecting
the hormonal effects of testosterone.8
The Heart manuscript by Shen et al9
expands on this important theme, investi-
gating whether CT calcium scoring is
likely to be of clinical use in patients with
bicuspid valves and in younger patients
with AS. Two hundred patients with a
range of stenosis severities were prospect-
ively recruited as a subgroup of the
PROGRESSA study. No patient in the
cohort had a history of rheumatic fever
and all had preserved left ventri-
cular systolic function. They underwent
Doppler echocardiography and CT
calcium scoring within a 3-month period,
allowing comparisons to be made between
the assessments of disease severity on the
two scans. In particular the authors inves-
tigated the agreement between the mean
transvalvular gradient on echocardiog-
raphy and the aortic valve calcium density
(AVCd) from CT. AVCd is a simple surro-
gate of the aortic valve calcium score but
indexes it to the cross-sectional area of
the left ventricular outflow tract to
account for different valve sizes. It may
offer incremental diagnostic accuracy in
determining AS severity using cut-offs of
AVCd 292 AU/cm2 in women and
476 AU/cm2 in men.2
Twenty per cent of the cohort had a
bicuspid aortic valve and 80% a trileaflet
valve. As expected the latter were older
(median age 72 years vs 51 years), more
likely to be male (76% vs 56%) and had
more comorbidities. In these patients with
trileaflet valves a good correlation was
observed between increasing AVCd and
MG (ρ=0.61, p<0.0001) that persisted in
both the younger (<72 years) and older
(≥72 years) age groups. The story
however appeared different in the cohort
of patients with a bicuspid aortic valve.
While patients ≥51 years in this group
still demonstrated a strong correlation
between AVCd and MG (p=0.55,
p=0.009) no correlation was observed in
patients aged <51 years with a bicuspid
aortic valve.
These observations have important
implications both with respect to the
utility of CT calcium scoring and the
likely pathobiology underlying valve
narrowing. First, it suggests that CT
calcium scoring is likely to be of clinical
utility in the vast majority of patients that
we encounter in the clinic: subjects with
trileaflet valves and patients >51 years
with a bicuspid valve. Moreover it indi-
cates that calcium is crucial to the patho-
physiology of valve narrowing in these
patients and therefore an important
potential therapeutic target.5
However it also implies that CT
calcium scoring may grossly underesti-
mate the severity of AS in young patients
under 50 years with a bicuspid valve.
This imaging technique should therefore
be approached with caution in this sub-
group and probably avoided. What is the
pathophysiological explanation for this
anomaly? Perhaps the first question to
address is whether it predominantly
represents a function of the bicuspid
structure of the valve or of patient age
(subjects in this group were substantially
younger than the patients in the trileaflet
group). The authors postulate several
explanations related to the former: that
bicuspid valves may suffer from leaflet
fibrosis rather than calcification; that
abnormalities in the morphology of the
leaflets and valve orifice lead to increased
gradients and reduced effective orifice
area; or that the eccentric jets associated
with bicuspid valves cause a pressure
drop in excess of the reduction in effect-
ive orifice area. While each is plausible,
why these factors would affect younger
patients with bicuspid valve disease but
not older subjects remains unclear. The
alternative explanation is that this phe-
nomenon instead simply reflects a func-
tion of age. As discussed the patients not
demonstrating a correlation between MG
and AVCd were substantially younger
than the other subjects in the study. The
lack of calcium in the valves of these
patients might therefore reflect a different
pathological process in those under the
age of 50 years, who also appear less
prone to calcification in other conditions.
Further work in this area is required.
Interestingly we recently encountered a
58-year-old female patient that might
support this hypothesis. She had a trileaf-
let aortic valve and no history of rheum-
atic heart disease or hyperlipidaemia.
Echocardiographic measurements were dis-
crepant but suggested at least moderate AS
(peak velocity 3.6 m/s, MG 27 mm Hg,
AVA 0.8 cm2). However her CT calcium
score indicated only minimal calcification
(36 AU, AVCd of 12.7 AU/cm2), appar-
ently out of keeping with the degree of
her valve narrowing. A contrast CT was
performed and provided explanation
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demonstrating extensive valve thickening
and narrowing, in the absence of calcifica-
tion but with appearances consistent with
fibrosis (figure 1). While anecdotal and
lacking histological validation, this case
illustrates that young patients may develop
advanced AS in the absence of major
valve calcification and supports a differ-
ence in their underlying pathobiology.
Alternative imaging and therapeutic strat-
egies may therefore be required in these
patients compared with the broader popu-
lation with AS.
In summary Shen et al are to be congra-
tulated on their innovative study. Indeed
there is a need for more such studies to
inform about which patients with AS
would benefit from CT imaging and to
provide further insights into the com-
plex pathophysiology underlying this
condition.
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Figure 1 A 58-year-old woman with aortic stenosis investigated by echocardiography and CT. (A) Doppler echocardiography demonstrating a peak
aortic valve (AV) velocity of 3.6 m/s, a mean gradient of 27 mm Hg and an aortic valve area (AVA) of 0.8 cm2 based upon the continuity equation.
(B) Non-contrast calcium scoring CT in the axial plane showing minimal aortic valve calcification (AV calcium score 37 AU). (C) Images from
contrast-enhanced CT in the en face plane and (D) coronal plane revealing marked leaflet thickening with low attenuation signal suggestive of valve
fibrosis. AO, aorta; AV, aortic valve; AVA, aortic valve areas; PG, pressure gradient; VTI, velocity time integral.
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